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Abstract
Background: Restraint stress in rodents has been reported to activate the hypothalamic-pituitary-adrenocortical
(HPA) axis and to increase c-fos expression in regions that express components of the corticotropin-releasing factor
(CRF) system. We have previously reported that acute central administration of CRF increased a measure of relative
local cerebral glucose utilization (LCGU), a measure of neuronal activity in specific brain regions, and activated the
HPA axis in mice. It was hypothesized that the involvement of the CRF system in the stress response would lead to
similar changes in relative LCGU after restraint stress. In the present studies the effect of restraint stress on relative
LCGU and on the HPA axis in C57BL/6N mice were examined.
Findings: Restraint stress activated the HPA axis in a restraint-duration dependent manner, but in contrast to the
reported effects of CRF, significantly decreased relative LCGU in frontal cortical, thalamic, hippocampal and
temporal dissected regions. These findings support evidence that stressors enforcing limited physical activity
reduce relative LCGU, in contrast to high activity stressors such as swim stress.
Conclusions: In conclusion, the present studies do not support the hypothesis that stress-induced changes in
relative LCGU are largely mediated by the CRF system. Further studies will help to delineate the role of the CRF
system in the early phases of the relative LCGU response to stress and investigate the role of other
neurotransmitter systems in this response.
Background
Restraint stress has been reported to activate the
hypothalamic-pituitary-adrenocortical (HPA) axis [1-6],
and has also been reported to increase c-fos expression
in regions that express components of the corticotropin-
releasing factor (CRF) system [7-10]. We have previously
reported that acute central administration of CRF
increased a measure of relative local cerebral glucose
utilization (LCGU) [11], a measure of neuronal activity
in specific brain regions [12]. Therefore, it was hypothe-
sized that the involvement of the CRF system in the
stress response would lead to similar changes in relative
LCGU after restraint stress. The aim of the present
study was to examine the effects of restraint stress on
relative LCGU.
To study the effects of restraint stress on relative
LCGU and the HPA axis, relative LCGU and plasma
corticosterone were measured after various durations of
restraint stress. Furthermore, to verify that the tracer
dose of 2DG used to measure relative LCGU was well
below the threshold for activation of the HPA axis, the
effect of 2-Deoxy-D-glucose on plasma corticosterone
was measured independently.
Methods
Male C57BL/6N mice (Janvier, France; mean body weight
at testing 26.9 ± 1 g) were individually housed in indivi-
dually-ventilated cages with food and water available ad
libitum (12 h/12 h light-dark cycle (lights on 06:00
hours), temperature 22 ± 0.5°C, humidity of 50 ± 3%). All
testing (randomized, between 07:00 and 12:00 hours) was
conducted according to the European Communities
Council Directive Nov. 1986 (86/609/EEC) and was
approved by the animal care and use committee of John-
son & Johnson Pharmaceutical Research & Development.
For the measurement of relative LCGU, 2-deoxy-D-[1-
3H]glucose (2DG; GE Healthcare, UK) (300 μCi/kg) was
injected intraperitoneally immediately before restraint
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technique does not account for inter-subject variability
as comprehensively as the original technique with
repeated blood sampling, it minimizes both stress and
effects on the animals’ physiology induced by blood
sampling. For the restraint stress, mice were removed
from their home cage, injected with 2DG then placed in
well ventilated stainless steel restraining tubes (9 cm
length, 3 cm diameter) for between 2 and 45 minutes.
Mice receiving restraint stress for less than the full
45 minute duration of the LCGU protocol were
returned to their home cage for the remainder of the
protocol duration. 45 minutes after 2DG injection,
blood and brain were collected for analysis.
Trunk blood was collected in BD Microtainer K2E
tubes (BD Vacutainer Systems, UK), 10 μlo fw h o l e
blood was used to measure blood glucose using a Life-
scan glucose meter (Lifescan Benelux, Belgium), and the
remainder was centrifuged at 1100 g for 10 minutes to
separate plasma from red blood cells. Plasma samples
were collected for measurement of plasma
3H( r e s i d u a l
2DG) and corticosterone and stored at -80°C.
After blood collection the brains were dissected into
frontal cortical area (anterior to corpus callosum),
hypothalamus, thalamus, cerebellum, hindbrain (a block
defined from the colliculi to the posterior level of the
cerebellum), hippocampus and temporal region (includ-
ing the amygdala). Tissue samples were weighed, and
stored at -80°C until homogenization. Brain samples
were dissolved using Solvable tissue solubilizer (Perkin
Elmer, Belgium).
3H in plasma and brain samples was
measured in duplicate in a TopCount NXT (PerkinEl-
mer, Belgium) microplate scintillation counter after
addition of Microscint-40 scintillant (PerkinElmer, Bel-
gium). A relative measure of LCGU was calculated as
nCi
3H present per mg of brain tissue.
To verify that the tracer dose of 2DG used to measure
relative LCGU had no effect on the HPA axis, the effect
of 2-Deoxy-D-glucose on plasma corticosterone was
measured. 2-Deoxy-D-glucose (non-radiolabelled; Sigma
Aldrich, Germany) was injected intraperitoneally at doses
from 5-400 mg/kg in saline vehicle. After 45 minutes
plasma was collected as described above for the measure-
ment of plasma corticosterone. Plasma corticosterone
was measured using ImmuchemTM Double Antibody
corticosterone
125I RIA kits (MP Biomedicals, USA).
The data were statistically analyzed using the Kruskal-
Wallis (KW) test with post-hoc comparisons performed
by the Mann-Whitney (MW) test (SPSS v13.0, SPSS
Belux, Belgium) at a significance level of p = 0.05.
Results
45 minutes of restraint significantly reduced relative
LCGU (nCi/mg) in the frontal cortical (p = 0.007), thala-
mic (p = 0.001), hippocampal (p = 0.006) and temporal
(p = 0.034) dissected regions (Table 1). The largest
decrease was seen in the thalamic region in which relative
LCGU was reduced from 0.22 ± 0.02 nCi/mg to 0.15 ±
0.01 nCi/mg. Relative LCGU was not significantly reduced
by shorter durations of restraint. No changes in final
plasma
3H levels (residual plasma 2DG) or blood glucose
were found after any duration of restraint stress studied
(Table 2). No relationship was found between blood glu-
cose and relative LCGU in any of the altered regions.
Plasma corticosterone levels were increased in a restraint-
duration dependent manner (Table 2) from 2 min (p =
0.016) to 5 min (p = 0.019), 10 min (p = 0.006), 20 min
(p = 0.001) and 45 min (p < 0.001). Control plasma corticos-
terone levels were 65 ± 15 ng/ml and the maximum level
after 45 minutes of restraint stress was 323 ± 11 ng/ml.
Administration of unlabelled 2DG resulted in a dose-
dependent increase in plasma corticosterone after
45 minutes (Figure 1), only reaching statistical signifi-
cance at the 200 and 400 mg/kg doses (p = 0.026 and
0.015) (equivalent to approximately 20 Ci/kg and 40 Ci/
kg, respectively, when compared to 2DG used to mea-
sure relative LCGU at a typical specific activity of 8 Ci/
mmol), more than one thousand-fold higher than the
dose used to measure LCGU (approx 3 μg/kg at an
injected dose of 300 μCi/kg).
Discussion
The present studies aimed to examine the effects of
acute restraint stress on relative LCGU, allowing a
Table 1 The effect of different durations of restraint stress on relative LCGU in mice (n = 8-10) (*p < 0.05)
Restraint Stress Relative LCGU (nCi/mg)
Region Control 2 min 5 min 10 min 20 min 45 min
Frontal Cortical 0.27 ± 0.02 0.24 ± 0.03 0.22 ± 0.01 0.30 ± 0.02 0.24 ± 0.01 0.21 ± 0.02*
Hypothalamus 0.20 ± 0.01 0.19 ± 0.02 0.18 ± 0.01 0.22 ± 0.01 0.20 ± 0.02 0.18 ± 0.01
Thalamus 0.22 ± 0.02 0.19 ± 0.02 0.18 ± 0.02 0.24 ± 0.02 0.20 ± 0.02 0.15 ± 0.01*
Cerebellum 0.13 ± 0.01 0.11 ± 0.02 0.12 ± 0.02 0.13 ± 0.02 0.10 ± 0.01 0.09 ± 0.01
Hindbrain 0.10 ± 0.01 0.08 ± 0.01 0.08 ± 0.02 0.09 ± 0.01 0.07 ± 0.01 0.06 ± 0.01
Hippocampus 0.15 ± 0.01 0.13 ± 0.01 0.13 ± 0.01 0.16 ± 0.00 0.14 ± 0.01 0.12 ± 0.01*
Temporal 0.18 ± 0.01 0.15 ± 0.01 0.15 ± 0.01 0.25 ± 0.06 0.16 ± 0.01 0.15 ± 0.01*
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CRF system on relative LCGU and the HPA axis pre-
viously reported [11].
In contrast to the increases in relative LCGU demon-
strated after the administration of CRF [11], relative
LCGU was reduced in selected brain regions after 45
minutes of restraint stress by up to 32% (in the thalamic
region; Table 1). The opposing effects of restraint stress
on relative LCGU compared to CRF administration sug-
gest that restraint stress-induced changes in relative
LCGU are unlikely to be mediated by a similar mechan-
ism involving CRF. However, it is also possible that the
relative LCGU decreases after restraint stress represent
a prolonged response involving multiple neurotransmit-
ter systems. This prolonged response may override
initial effects of CRF release on relative LCGU. Reduc-
tions in LCGU have also been reported after stressors
including an inactivity component such restraint in cold
water and four-limb immobilization [13,14]. In the pre-
sent study, the influence of the additional stress compo-
nents, namely cold water and exposure during
immobilization, in these studies was avoided, as conflict-
ing effects on LCGU have been reported depending on
the stressor studied. Indeed, increases in LCGU after
swim stress have been reported in prefrontal cortical
areas, motor cortex and lateral septum, and these effects
matched with increased fos-like-immunoreactivity in
these areas [15]. Reduced LCGU in the hippocampus,
inferior colliculus, orbital cortex, and insula after swim
stress has been reported, but LCGU was simultaneously
increased in striatum and cerebellum [16,17]. Differ-
ences in the physical context of a stressor could explain
contradictory findings for LCGU alterations. For exam-
ple, restraint/immobility could be considered to reflect
stressors with (imposed) limited physical activity, while
clearly forced swim stress requires a large activity com-
ponent. Interestingly, the forced swim stress-induced
increase in LCGU in the lateral septum was blocked by
treatment with imipramine [15], which in this acute
context implicates the serotonergic and noradrenergic
systems in these LCGU changes. However, swim-stress-
induced changes in LCGU are also sensitive to tempera-
ture [18], meaning that care must be taken in compar-
ing studies with different methodology.
Activation of the HPA axis after restraint stress
(Table 2) agrees with reports from the literature [1-6],
and is similar to that seen after central administration of
CRF or the related endogenous peptides Urocortin 1, 2
and 3 [11]. These changes cannot be attributed to a
direct effect of 2DG on the HPA axis, as plasma corti-
costerone was only increased at doses >100 mg/kg,
while the tracer amount of 2DG used to measure rela-
tive LCGU equates to approximately 3 μg/kg. This
agrees with previously reported data [19-21], in which
2DG was capable of activating the HPA axis at doses
>100 mg/kg. The present study could have been
improved by the inclusion of a dose of 2DG more clo-
sely matching the tracer dose used for LCGU measure-
ments. Through competition with intracellular glucose,
2DG inhibits phosphohexose isomerase [22,23] and
thereby blocks glycolysis at the initiation stage. There-
fore, at sufficient doses, 2DG is expected to cause deple-
tion of ATP as well as of glucose derivatives required
for protein glycosylation [24], constituting a pharmaco-
logical stressor through energy depletion. The use of a
tracer dose of 2DG which is only sufficient for the mea-
surement of relative LCGU ensures that this effect is
avoided in studies of central glucose metabolism.
Glucocorticoid feedback after activation of the HPA
a x i sm a yp l a yar o l ei nL C G Uc h a n g e sd u r i n gs t r e s s ,
particularly in regions associated with the HPA axis
negative feedback loop, such as the hippocampus
Table 2 The effect of different durations of restraint stress on residual plasma 2DG, blood glucose and plasma
corticosterone in mice (n = 8-10) (*p < 0.05)
Treatment Residual plasma 2DG (nCi/ml) Blood glucose (mg/dl) Plasma corticosterone (ng/ml)
Control 44 ± 3 135 ± 9 65 ± 15
2 min 57 ± 12 163 ± 9 127 ± 23*
5 min 57 ± 10 154 ± 12 112 ± 17*
10 min 49 ± 3 136 ± 11 146 ± 23*
20 min 50 ± 3 154 ± 8 188 ± 18*
45 min 49 ± 6 144 ± 22 323 ± 11*
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Figure 1 The effect of intraperitoneally administered 2DG on
the HPA axis. (n = 6/group). *p < 0.05.
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numerous peripheral tissues is to inhibit glucose
uptake into cells [27,28], and studies have shown that
in hippocampal cell cultures glucocorticoids signifi-
cantly inhibit glucose uptake and oxidation both by
neurons and astrocytes [27,29], although exposure for
at least four hours appears to be necessary. Increased
LCGU following acute adrenalectomy in rats [30],
further indicates a negative modulatory role of gluco-
corticoids on cerebral glucose metabolism, and an
overall reduction in relative LCGU after direct admin-
istration of corticosterone has been reported [31],
although the authors attributed the effect to peripheral
changes in 2DG uptake. As similar evidence for a per-
ipheral effect on 2DG uptake, as measured by changes
in residual 2DG, was not found in the present study,
the reductions in relative LCGU seen in the brain in
the present study may be related to the increased cor-
ticosterone levels after restraint stress (Table 2).
Despite this activation of the HPA axis, no significant
effect on relative LCGU in the hypothalamic region
was detected (Table 1). The heterogeneous nature of
the overall hypothalamic region may explain the lack
of a detected effect in this dissected region, although
in a study with a similar methodology [31] an increase
in hypothalamic relative LCGU was detected after foot-
shock. Activation of the HPA axis would be expected
to primarily involve the paraventricular nucleus [4,32],
which comprises only a small fraction of the dissected
region. This highlights a drawback of the present
methodology. Further studies using higher resolution
techniques, such as autoradiography would allow more
detailed study of changes in the hypothalamus.
Restraint (and other stressors) has been reported to
increase blood glucose levels [3,5,6,13,33]. As described
in the original assumptions of the LCGU model [12],
sufficient variations in blood glucose may influence the
measurement of LCGU. For this reason, blood glucose
was measured of as part of the relative LCGU protocol.
No significant changes in blood glucose were found
(Table 2), indicating that this variable should not have
adversely affected relative LCGU measurements. How-
ever, a weakness of the present methodology is that an
end point glucose measurement may miss transient
changes during the 45 minute protocol. The absence of
ac h a n g ei nb l o o dg l u c o s ec ompared to studies in the
literature may reflect strain differences as mice of a
similar strain (C57BL/6J) were only used in one of the
above studies [5]. Furthermore, in that study the mice
were restrained for 1 hour, and shaken for 10 minutes
during that period. This may constitute a much greater
stressor than restraint alone, and the reduced duration
of restraint stress used in the present study may contri-
bute to the different findings.
In conclusion, the present studies do not support the
hypothesis that restraint stress would induce similar
changes in relative LCGU to those induced by CRF.
However, the changes seen support evidence that stres-
sors enforcing limited physical activity reduce LCGU
globally.
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